Considerations for cancer immunotherapy during the COVID-19 pandemic.
Considerations for cancer immunotherapy during the COVID-19 pandemic.
Med J Aust. 2020 Oct 08;:
Authors: Kanjanapan Y, Yip D
PMID: 33034044 [PubMed - as supplied by publisher]
Source: Medical Journal of Australia - Category: General Medicine Tags: Med J Aust Source Type: research
More News: Australia Health | Cancer | Cancer & Oncology | COVID-19 | General Medicine | Immunotherapy | Pandemics